Royce & Associates LP Boosts Stock Position in BrightSpring Health Services, Inc. $BTSG

Royce & Associates LP raised its holdings in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 32.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 182,538 shares of the company’s stock after buying an additional 44,505 shares during the period. Royce & Associates LP’s holdings in BrightSpring Health Services were worth $5,396,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of BTSG. EverSource Wealth Advisors LLC bought a new stake in shares of BrightSpring Health Services during the second quarter worth $43,000. CWM LLC increased its stake in BrightSpring Health Services by 105.3% in the 3rd quarter. CWM LLC now owns 1,595 shares of the company’s stock worth $47,000 after buying an additional 818 shares during the period. Amalgamated Bank lifted its holdings in BrightSpring Health Services by 62.7% during the 3rd quarter. Amalgamated Bank now owns 3,041 shares of the company’s stock valued at $90,000 after buying an additional 1,172 shares in the last quarter. Sandia Investment Management LP purchased a new stake in BrightSpring Health Services in the 2nd quarter valued at about $118,000. Finally, Penserra Capital Management LLC bought a new position in BrightSpring Health Services in the 2nd quarter worth about $139,000.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Zacks Research downgraded shares of BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 6th. Wall Street Zen downgraded BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 15th. Bank of America lifted their target price on BrightSpring Health Services from $38.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Mizuho upped their target price on BrightSpring Health Services from $45.00 to $50.00 and gave the stock an “outperform” rating in a report on Tuesday. Finally, William Blair assumed coverage on BrightSpring Health Services in a research note on Monday, December 8th. They set an “outperform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, BrightSpring Health Services currently has an average rating of “Moderate Buy” and an average target price of $44.08.

BrightSpring Health Services Stock Performance

Shares of NASDAQ:BTSG opened at $41.96 on Thursday. The firm has a 50 day moving average of $39.34 and a 200 day moving average of $33.72. The company has a quick ratio of 1.12, a current ratio of 1.57 and a debt-to-equity ratio of 1.32. The company has a market capitalization of $8.12 billion, a price-to-earnings ratio of 47.68, a price-to-earnings-growth ratio of 0.56 and a beta of 2.31. BrightSpring Health Services, Inc. has a 52 week low of $15.48 and a 52 week high of $44.87.

BrightSpring Health Services (NASDAQ:BTSG) last announced its earnings results on Friday, February 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.01). The company had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The firm’s revenue was up 29.3% compared to the same quarter last year. During the same period last year, the business posted $0.11 EPS. On average, sell-side analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

Key Headlines Impacting BrightSpring Health Services

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Morgan Stanley raised its price target to $48 and kept an “overweight” rating, signaling institutional confidence and giving investors a visible upside reference. Morgan Stanley Raises PT
• Positive Sentiment: Mizuho bumped its target to $50 with an “outperform” rating, another upward revision that supports buyer interest. Mizuho Raises PT
• Positive Sentiment: Wells Fargo increased its price target to $50, adding to analyst-driven upward pressure on the stock. Wells Fargo Raises PT
• Positive Sentiment: Zacks placed BTSG on its Rank #1 (Strong Buy) momentum list and published bullish commentary highlighting recent fast-paced momentum at a reasonable valuation — coverage that can attract momentum and retail flows. Zacks Momentum Pick
• Positive Sentiment: Additional Zacks coverage framed BTSG as a value/momentum opportunity, which may further widen the buyer base (value and momentum investors). Zacks Value/Momentum Analysis
• Neutral Sentiment: Short-interest data reported for early March is inconsistent/zero in the filings (reports show 0 shares and 0 days-to-cover), so it doesn’t provide a reliable signal for current short pressure or covering dynamics.
• Negative Sentiment: Secondary offering priced: existing shareholders (including a KKR affiliate and some management) are selling 20,000,000 shares at $41.15 per share; BrightSpring is not selling shares and receives no proceeds. The large block sale increases available float and likely added selling pressure/volume around the offering close, even though the company itself isn’t diluting equity. Secondary Offering & Repurchase

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.